Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn D Gartrell-Corrado

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Dermatology|October 12, 2019
Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in MelanomaEmanuelle M Rizk, Angelina M Seffens, Megan H Trager, et al.
Melanoma Research|May 8, 2020
Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvecClaire Audrey-Bayan, Megan H Trager, Robyn D Gartrell-Corrado, et al.
Journal for Immunotherapy of Cancer|August 15, 2019
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibitionJared M Newton, Aurelie Hanoteau, Hsuan-Chen Liu, et al.
Cell Reports|December 19, 2019
Tissue-Resident Memory T Cells Mediate Immune Homeostasis in the Human Pancreas through the PD-1/PD-L1 PathwayStuart P Weisberg, Dustin J Carpenter, Michael Chait, et al.
Cancer Research|January 18, 2020
Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary MelanomaRobyn D Gartrell-Corrado, Andrew X Chen, Emanuelle M Rizk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and DeathPrathamesh M Kulkarni, Eric J Robinson, Jaya Sarin Pradhan, et al.
Scientific Reports|February 3, 2021
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanomaMichael R Moore, Isabel D Friesner, Emanuelle M Rizk, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Dermatology|October 12, 2019
Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in MelanomaEmanuelle M Rizk, Angelina M Seffens, Megan H Trager, et al.
Melanoma Research|May 8, 2020
Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvecClaire Audrey-Bayan, Megan H Trager, Robyn D Gartrell-Corrado, et al.
Journal for Immunotherapy of Cancer|August 15, 2019
Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibitionJared M Newton, Aurelie Hanoteau, Hsuan-Chen Liu, et al.
Cell Reports|December 19, 2019
Tissue-Resident Memory T Cells Mediate Immune Homeostasis in the Human Pancreas through the PD-1/PD-L1 PathwayStuart P Weisberg, Dustin J Carpenter, Michael Chait, et al.
Cancer Research|January 18, 2020
Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary MelanomaRobyn D Gartrell-Corrado, Andrew X Chen, Emanuelle M Rizk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and DeathPrathamesh M Kulkarni, Eric J Robinson, Jaya Sarin Pradhan, et al.
Scientific Reports|February 3, 2021
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanomaMichael R Moore, Isabel D Friesner, Emanuelle M Rizk, et al.
Pageof 1